A new bioinformatics insight into human cancer-associated proteins

Oncology Reports

Volumn 27, Issue 6, 2012, Pages 1932-1936

  Liu, Fu Jun ^a   Hua, Xiu Feng ^a   Wang, Wen Juan ^a  

^a QINGDAO UNIVERSITY   (China)

Author keywords

Bioinformatics; Biomarker; Cancer; Cancer testis antigen; Proteome

Indexed keywords

CANCER TESTIS ANTIGEN; CELL SURFACE PROTEIN; GLYCOSAMINOGLYCAN; ONCOPROTEIN; PROTEIN P53; SECRETORY PROTEIN; TUMOR MARKER;

APOPTOSIS; ARTICLE; BIOINFORMATICS; BLADDER CANCER; BREAST CANCER; CANCER RESEARCH; CARCINOGENESIS; CELL ADHESION; CELL CYCLE PHASE; COLORECTAL CANCER; DEGRADATION KINETICS; DISEASE ASSOCIATION; DISEASE MARKER; FUNCTIONAL PROTEOMICS; HUMAN; INTRACELLULAR SIGNALING; METASTASIS; MOLECULAR MODEL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

COMPUTATIONAL BIOLOGY; DATA MINING; DATABASES, PROTEIN; HUMANS; NEOPLASM PROTEINS; NEOPLASMS; PROTEOME; PROTEOMICS; TUMOR MARKERS, BIOLOGICAL;

EID: 84860751571     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2012.1714     Document Type: Article

References (33)

1. Pfeifer GP and Hainaut P: Next-generation sequencing: emerging lessons on the origins of human cancer. Curr Opin Oncol 23: 62-68, 2011.
2. Ajani J and Allgood V: Molecular mechanisms in cancer: what should clinicians know? Semin Oncol 32: 2-4, 2005.
3. Aggarwal C, Somaiah N and Simon GR: Biomarkers with predictive and prognostic function in non-small cell lung cancer: ready for prime time? J Natl Compr Cancer Netw 8: 822-832, 2010.
4. Sung HJ and Cho JY: Biomarkers for the lung cancer diagnosis and their advances in proteomics. BMB Rep 41: 615-625, 2008.
5. Kim SY: A new paradigm for cancer therapeutics development. BMB Rep 43: 383-388, 2010.
6. Abu-Asab MS, Chaouchi M, Alesci S, Galli S, Laassri M, Cheema AK, Atouf F, VanMeter J and Amri H: Biomarkers in the age of omics: time for a systems biology approach. OMICS 15: 105-112, 2011.
7. Dunn BK, Wagner PD, Anderson D and Greenwald P: Molecular markers for early detection. Semin Oncol 37: 224-242, 2010.
8. Ludwig JA and Weinstein JN: Biomarkers in cancer staging, prognosis and treatment selection. Nat Rev Cancer 5: 845-856, 2005. (Pubitemid 41746029)
9. Wistuba II, Gelovani JG, Jacoby JJ, Davis SE and Herbst RS: Methodological and practical challenges for personalized cancer therapies. Nat Rev Clin Oncol 8: 135-141, 2011.
10. Schmitz-Spanke S and Rettenmeier AW: Protein expression profiling in chemical carcinogenesis: a proteomic-based approach. Proteomics 11: 644-656, 2011.
11. Hassanein M, Rahman JS, Chaurand P and Massion PP: Advances in proteomic strategies toward the early detection of lung cancer. Proc Am Thorac Soc 8: 183-188, 2011.
12. Goncalves A and Bertucci F: Clinical application of proteomics in breast cancer: state of the art and perspectives. Med Princ Pract 20: 4-18, 2011.
13. Tjalsma H: Identification of biomarkers for colorectal cancer through proteomics-based approaches. Expert Rev Proteomics 7: 879-895, 2010.
14. Schwamborn K, Gaisa NT and Henkel C: Tissue and serum proteomic profiling for diagnostic and prognostic bladder cancer biomarkers. Expert Rev Proteomics 7: 897-906, 2010.
15. Larkin SE, Zeidan B, Taylor MG, Bickers B, Al-Ruwaili J, Aukim-Hastie C and Townsend PA: Proteomics in prostate cancer biomarker discovery. Expert Rev Proteomics 7: 93-102, 2010.
16. Schaaij-Visser TB, Brakenhoff RH, Leemans CR, Heck AJ and Slijper M: Protein biomarker discovery for head and neck cancer. J Proteomics 73: 1790-1803, 2010.
17. Zhang B, Barekati Z, Kohler C, Radpour R, Asadollahi R, Holzgreve W and Zhong XY: Proteomics and biomarkers for ovarian cancer diagnosis. Ann Clin Lab Sci 40: 218-225, 2010.
18. Issaq HJ, Waybright TJ and Veenstra TD: Cancer biomarker discovery: opportunities and pitfalls in analytical methods. Electrophoresis 32: 967-975, 2011.
19. Sawyers CL: The cancer biomarker problem. Nature 452: 548-552, 2008.
20. Liu F, Wang H and Li J: An integrated bioinformatics analysis of mouse testis protein profiles with new understanding. BMB Rep 44: 347-351, 2011.
21. Dinicola S, D'Anselmi F, Pasqualato A, Proietti S, Lisi E, Cucina A and Bizzarri MA: Systems biology approach to cancer: fractals, attractors, and non-linear dynamics. OMICS 15: 93-104, 2011.
22. Coradini D, Casarsa C and Oriana S: Epithelial cell polarity and tumorigenesis: new perspectives for cancer detection and treatment. Acta Pharmacol Sin 32: 552-564, 2011.
23. Martin TA, Mason MD and Jiang WG: Tight junctions in cancer metastasis. Front Biosci 16: 898-936, 2011.
24. Kim SH, Turnbull J and Guimond S: Extracellular matrix and cell signalling: the dynamic cooperation of integrin, proteoglycan and growth factor receptor. J Endocrinol 209: 139-151, 2011.
25. Wijnhoven BP, Dinjens WN and Pignatelli M: E-cadherin-catenin cell-cell adhesion complex and human cancer. Br J Surg 87: 992-1005, 2000. (Pubitemid 30496847)
26. Berx G and Van Roy F: The E-cadherin/catenin complex: an important gatekeeper in breast cancer tumorigenesis and malignant progression. Breast Cancer Res 3: 289-293, 2001. (Pubitemid 32851157)
27. Tan C, Costello P, Sanghera J, Dominguez D, Baulida J, de Herreros AG and Dedhar S: Inhibition of integrin linked kinase (ILK) suppresses beta-catenin-Lef/Tcf-dependent transcription and expression of the E-cadherin repressor, snail, in APC-/- human colon carcinoma cells. Oncogene 20: 133-140, 2001. (Pubitemid 32142346)
28. Bravou V, Klironomos G, Papadaki E, Taraviras S and Varakis J: ILK over-expression in human colon cancer progression correlates with activation of beta-catenin, down-regulation of E-cadherin and activation of the Akt-FKHR pathway. J Pathol 208: 91-99, 2006. (Pubitemid 43025707)
29. Cortez V, Nair BC, Chakravarty D and Vadlamudi RK: Integrin-linked kinase 1: role in hormonal cancer progression. Front Biosci (Schol Ed) 3: 788-796, 2011.
30. da Cunha JP, Galante PA, de Souza JE, de Souza RF, Carvalho PM, Ohara DT, Moura RP, Oba-Shinja SM, Marie SK, Silva WA Jr, et al: Bioinformatics construction of the human cell surfaceome. Proc Natl Acad Sci USA 106: 16752-16757, 2009.
31. Grigoriadis A, Caballero OL, Hoek KS, da Silva L, Chen YT, Shin SJ, Jungbluth AA, Miller LD, Clouston D, Cebon J, et al: CT-X antigen expression in human breast cancer. Proc Natl Acad Sci USA 106: 13493-13498, 2009.
32. Wei X, Moncada-Pazos A, Cal S, Soria-Valles C, Gartner J, Rudloff U, Lin JC, NISC Comparative Sequencing Program, Rosenberg SA, López-Otín C and Samuels Y: Analysis of the disintegrin-metalloproteinases family reveals ADAM29 and ADAM7 are often mutated in melanoma. Hum Mutat 32: E2148-E2175, 2011.
33. Polanski M and Anderson NL: A list of candidate cancer biomarkers for targeted proteomics. Biomark Insights 1: 1-48, 2007.